• share
• favorite_border

“We were uniquely positioned to take the evidence gleaned from our ongoing effort to address why firefighters are at increased risk of cancer incidence and mortality and rapidly translate it to a disaster that could augment this risk substantially,” said Dr. Kobetz, Sylvester’s associate director for population sciences and cancer disparity and the University of Miami’s vice provost for research and scholarship. “Our hope is that we and our firefighter colleagues learn together how to mitigate the risks that emerge in a different disaster scenario.”

• share
• favorite_border

In a new National Institutes of Health (NIH) initiative, the University of Miami Miller School of Medicine was selected for a nationwide Liver Cirrhosis Network. Researchers in the network’s 10 academic medical centers will share patient data and launch clinical trials of a class of medications that could prevent progression of the disease, which causes irreversible scarring of the liver, and complications such as liver cancer.

• share
• favorite_border

Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation’s most pressing healthcare challenges.

• share
• favorite_border

The University of Miami’s Miller School of Medicine will be one of only three sites in the nation to test a potentially revolutionary opto-electrical cochlear implant, which could improve quality of life for millions with hearing loss.

• share
• favorite_border

Researchers at the Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine, Moffitt Cancer Center and the University of Florida Health Cancer Center received a five-year, $3.95 million NIH grant to study how uveal melanoma spreads to the liver. This work was previously supported by two Florida State Team Science Awards, which provided early-stage funding to help the team progress to the larger NIH grant.

• share
• favorite_border

A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.

• share
• favorite_border

Three years after the National Institutes of Health (NIH) launched its 10-year All of Us Research Program, a regional team led by University of Miami Miller School of Medicine faculty has achieved remarkable success in recruiting members of minority communities including Black and Latino participants.

• share
• favorite_border

In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.

• share
• favorite_border

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.

• share
• favorite_border

• share
• favorite_border

The University of Miami Miller School of Medicine is helping to lead a National Institutes of Health (NIH) COVID-19 testing initiative to safely return children to in-person school.

• share
• favorite_border

Declining health and fitness are commonly known to accompany spinal cord injuries and disorders (SCI/D). During the past few decades, attention has also focused on including five critical health hazards: overweight/obesity, insulin resistance, hypertension, and lipid abnormalities.

• share
• favorite_border

A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.

• share
• favorite_border

• share
• favorite_border

There is also the emerging understanding that overcoming systemic racism helps ensure that everyone has a chance to access advanced education and training. To help drive this change, the Department of Neurological Surgery at the University of Miami Miller School of Medicine has established the Black Lives Matter Fellowship to support Black students who want to conduct advanced work in neuroscience or neurosurgery.

• share
• favorite_border

To many, heart failure means a person is at the end of life, struggling for breath. But that is not reality for most heart failure patients. The Cardiovascular Division at the University of Miami Miller School of Medicine is addressing the needs of today’s heart failure patients by expanding the Heart Failure program to not only care for those with advanced heart failure but to also help patients with the disease live full lives, and to help those at risk for heart failure.

• share
• favorite_border

The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.

• share
• favorite_border

• share
• favorite_border

The $2.3 million, four-year Avenir Award will support his innovative research project, “Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People Who Inject Drugs: A Randomized Controlled Trial.”

• share
• favorite_border

Clinician researchers at the University of Miami Miller School of Medicine have shown that patients don’t necessarily need opioids for pain relief following robotic prostatectomies. In a study published in the Journal of Robotic Surgery, the team found that strategic use of local anesthetic and non-steroidal anti-inflammatory drugs (NSAIDs) plus acetaminophen can effectively control post-surgical pain without narcotics.

• share
• favorite_border

Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.

• share
• favorite_border

According to a new study caffeine withdrawal can be a severe problem for surgery patients, who can’t eat or drink anything for hours before their procedures. This can result in major side effects, complicate treatment and extend hospital stays.

• share
• favorite_border

University of Miami Miller School of Medicine researchers report the widespread blood vessel dysfunction, or endothelial dysfunction, that results from the COVID-19 infection could contribute to erectile dysfunction, or ED, according to a study published in the World Journal of Men’s Health .

• share
• favorite_border

From the impact of COVID-19 on parents, to speech differences between English- and Spanish-learners, and advanced ear surgery techniques, University of Miami Miller School of Medicine hearing professionals presented their latest studies at CI2021, the annual conference of the American Cochlear Implant (ACI) Alliance, from April 28 to May 1.

• share
• favorite_border

A new study led by a University of Miami Miller School of Medicine researcher underscores the importance of screening adolescents with hearing loss for depression and anxiety.

• share
• favorite_border

David Goldberg, M.D., M.S.C.E., associate professor of medicine in the Division of Digestive Health and Liver Diseases at the University of Miami Miller School of Medicine, is one of three principal investigators of a five-year, $7.8 million National Institutes of Health-funded study using donor kidneys infected with hepatitis C (HCV) in patients awaiting kidney transplants who do not have HCV.

• share
• favorite_border

Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals Incorporated have initiated clinical trials for VX-880, a novel investigational cell therapy with the potential to restore normal glucose control in people suffering from type 1 diabetes with severe hypoglycemia and impaired hypoglycemic awareness. The University of Miami Health System was the first clinical site activated for this trial.

• share
• favorite_border

American Urological Association Awards 3 Grants to Miller School Researchers